Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Mosholder

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
JAMA Psychiatry|September 5, 2019
Challenges of Suicide Outcomes Ascertainment in Administrative Claims DatabasesDinci D Pennap, Andrew D Mosholder, Richard S Swain
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 10, 2022
Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosisManila Hada, Andrew D Mosholder, Kira Leishear, et al.
Journal of Child and Adolescent Psychopharmacology|May 17, 2019
Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89)Andrew D Mosholder, Jean Kim, Michael Davis, et al.
The Journal of Pediatrics|September 8, 2009
Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult casesPaula Gish, Andrew D Mosholder, Melissa Truffa, et al.
The New England Journal of Medicine|May 3, 2013
Cardiovascular risks with azithromycin and other antibacterial drugsAndrew D Mosholder, Justin Mathew, John J Alexander, et al.
The Journal of Clinical Psychiatry|June 5, 2019
Antipsychotic Use and Stroke: A Retrospective Comparative Study in a Non-Elderly PopulationLockwood G Taylor, Genna Panucci, Andrew D Mosholder, et al.
Pediatrics|January 28, 2009
Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in childrenAndrew D Mosholder, Kate Gelperin, Tarek A Hammad, et al.
Japanese Journal of Infectious Diseases|August 11, 2015
Nonsteroidal Anti-Inflammatory Drug and Aspirin Use, and Mortality among Critically Ill Pandemic H1N1 Influenza Patients: an Exploratory AnalysisHolly Epperly, Frances L Vaughn, Andrew D Mosholder, et al.
Pediatrics|October 26, 2011
Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonistsAnn W McMahon, Mark S Levenson, Bradley W McEvoy, et al.
Drug Safety|September 21, 2018
Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs"Courtney M Suggs, Robert L Levin, Andrew D Mosholder, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
JAMA Psychiatry|September 5, 2019
Challenges of Suicide Outcomes Ascertainment in Administrative Claims DatabasesDinci D Pennap, Andrew D Mosholder, Richard S Swain
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 10, 2022
Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosisManila Hada, Andrew D Mosholder, Kira Leishear, et al.
Journal of Child and Adolescent Psychopharmacology|May 17, 2019
Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89)Andrew D Mosholder, Jean Kim, Michael Davis, et al.
The Journal of Pediatrics|September 8, 2009
Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult casesPaula Gish, Andrew D Mosholder, Melissa Truffa, et al.
The New England Journal of Medicine|May 3, 2013
Cardiovascular risks with azithromycin and other antibacterial drugsAndrew D Mosholder, Justin Mathew, John J Alexander, et al.
The Journal of Clinical Psychiatry|June 5, 2019
Antipsychotic Use and Stroke: A Retrospective Comparative Study in a Non-Elderly PopulationLockwood G Taylor, Genna Panucci, Andrew D Mosholder, et al.
Pediatrics|January 28, 2009
Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in childrenAndrew D Mosholder, Kate Gelperin, Tarek A Hammad, et al.
Japanese Journal of Infectious Diseases|August 11, 2015
Nonsteroidal Anti-Inflammatory Drug and Aspirin Use, and Mortality among Critically Ill Pandemic H1N1 Influenza Patients: an Exploratory AnalysisHolly Epperly, Frances L Vaughn, Andrew D Mosholder, et al.
Pediatrics|October 26, 2011
Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonistsAnn W McMahon, Mark S Levenson, Bradley W McEvoy, et al.
Drug Safety|September 21, 2018
Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs"Courtney M Suggs, Robert L Levin, Andrew D Mosholder, et al.
Pageof 4